Morning Briefing
Summaries of health policy coverage from major news organizations
Oncologists Say They Don't Know Enough About Medical Marijuana But Will Still Prescribe It To Patients
Nearly half of U.S. cancer doctors who responded to a survey say they’ve recently recommended medical marijuana to patients, although most say they don’t know enough about medicinal use. The results reflect how marijuana policy in some states has outpaced research, the study authors said. All 29 states with medical marijuana programs allow doctors to recommend it to cancer patients. But no rigorous studies in cancer patients exist. That leaves doctors to make assumptions from other research on similar prescription drugs, or in other types of patients. (Johnson, 5/10)
“The majority feel like it has medical utility for some indications,” said Dr. Ilana Braun, chief of the division of adult psychosocial oncology at the Dana-Farber Cancer Institute in Boston, who led the new research. As an oncologist, Braun said, she hears a growing number of her own patients asking about medical marijuana. “I occasionally recommend it, but very carefully and it’s on an individual patient basis,” she said. (Weintraub, 5/10)
Anecdotal reports suggest marijuana is helpful in managing symptoms of chemotherapy, like pain and nausea. But it's unlikely curious patients are getting clear guidance from their doctors on whether they should try marijuana, which form might work best and how much to take. A new survey of 237 oncologists from around the country finds that while roughly 80 percent talk with their patients about marijuana, fewer than 30 percent feel they have sufficient knowledge to advise them about its medicinal use. (Herman, 5/10)